Beckman's Q1 Revenues Inch up 2 Percent

The company's Clinical Diagnostics segment was up 3 percent year over year, while Life Science slid 11 percent.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories